Atlas Trials

Additional Prognostic Value of Tumor Grade Beyond the 21-gene Recurrence Score

Clinical trial NCT07093775 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07093775
Sponsor
Gangnam Severance Hospital
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Breast CancerTumor Grade
Start date
2025-07-01
Primary completion
2025-12-01
Enrollment
4000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.